Sign in

CIK 0001737953

  • Non-accelerated filer
  • Smaller reporting company

Replimune Group, Inc.

Sign in to watch
Ticker
REPL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Mar 31
Incorporated
DE
Entity type
Operating
EIN
822082553
Phone
+1 781-222-9600
Business address
500 UNICORN PARK, WOBURN, MA, 01801
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$521,860
in 2 filings

Net −$521,860. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Dhingra Kapil −$409K Director sold 50% of stake
  2. SLATTERY JOSEPH P −$113K Director sold 78% of stake

Reading 83 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-05-03 Patel Sushil Chief Commercial Officer Grant or award · Employee Stock Option (right to buy) +125,000 125,000
2021-04-15 Love Colin Chief Operating Officer Sale −27,300 $30.69 $838K 898,509
2021-04-15 Love Colin Chief Operating Officer Sale −2,700 $29.98 $81K 895,809
2021-04-01 Esposito Pamela Chief Business Officer Grant or award +34,165 210,159
2021-04-01 Esposito Pamela Chief Business Officer Grant or award · Employee Stock Option (right to buy) +51,250 51,250
2021-04-01 Pirzkall Andrea Chief Medical Officer Grant or award +20,500 21,500
2021-04-01 Pirzkall Andrea Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +30,750 30,750
2021-04-01 Franchi Jean M. Chief Financial Officer Grant or award +46,035 46,035
2021-04-01 Franchi Jean M. Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +69,050 69,050
2021-04-01 Coffin Robert President & Chief R&D Officer Grant or award +76,865 1,820,983
2021-04-01 Coffin Robert President & Chief R&D Officer Grant or award · Employee Stock Option (right to buy) +115,300 115,300
2021-04-01 Astley-Sparke Philip Chief Executive Officer Grant or award +85,415 1,340,712
2021-04-01 Astley-Sparke Philip Chief Executive Officer Grant or award · Employee Stock Option (right to buy) +128,125 128,125
2021-04-01 Love Colin Chief Operating Officer Grant or award +39,285 925,809
2021-04-01 Love Colin Chief Operating Officer Grant or award · Employee Stock Option (right to buy) +58,925 58,925
2021-04-01 Rhodes Jason P Director Grant or award · Stock Option (right to buy) +16,500 16,500
2021-04-01 Levitsky Hyam Director Grant or award · Stock Option (right to buy) +16,500 16,500
2021-04-01 Lewis Tanya Director Grant or award · Stock Option (right to buy) +16,500 16,500
2021-04-01 Pucci Paolo Director Grant or award · Stock Option (right to buy) +16,500 16,500
2021-04-01 Weinand Dieter Director Grant or award · Stock Option (right to buy) +24,750 24,750

Page 14 of 19 · 365 trades